Boston Scientific Corporation (ETR:BSX)

Market Cap	128.05B
Revenue (ttm)	16.49B
Net Income (ttm)	2.38B
Shares Out	n/a
EPS (ttm)	1.59
PE Ratio	53.83
Forward PE	29.91
Dividend	n/a
Ex-Dividend Date	n/a

Volume	619
Average Volume	833
Open	85.60
Previous Close	84.80
Day's Range	85.00 - 85.60
52-Week Range	75.20 - 104.00
Beta	n/a
RSI	51.91
Earnings Date	Feb 5, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: BSX

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD